Search:

Login | Subscribe

Home > Companies > Genetix Group

Price	Market	Sector	Market Cap
53.50p (0.00p) 0.00%	AIM	Health Care and Related Services	£38.4m

Add to company folder | Print

Related Companies

FDT	7.62p	3.39%
AMS	30.00p	0.00%
AOR	267.50p	0.00%
AVG	54.50p	0.00%
BNX	p
CTN	21.00p	-4.54%
CUS	1.88p	0.00%
DSY	3.25p	0.00%
DEMG	18.50p	1.37%
HCEG	0.55p	0.00%
IDH	276.50p	0.00%
LID	9.38p	-1.32%
MDW	6.50p	0.00%
BPRG	p
NMT	p
NIM	2.50p	0.00%
OSH	p
PKL	p
SUN	1.75p	7.69%
MLH	17.50p	-2.78%
TSL	p
ZIM	p

Commentary

Cancer diagnostic and biotherapeutic technologies group

Recent Articles

New products help Genetix	07/08/2008
Maiden payout from Genetix	04/03/2008
Cell biology boosts Genetix	17/01/2008
Acquisition lifts Genetix sales	23/08/2007
Genetix	29/04/2004

Recent Announcements

Interim Results	07/08/2008
Board Changes	31/07/2008
Trading Update	16/07/2008
Result of AGM	07/05/2008
AGM Statement	07/05/2008
Director's Shareholding	07/04/2008
Annual Report and Accounts	01/04/2008
Blocklisting Interim Review	01/04/2008
Blocklisting Interim Review	01/04/2008
Blocklisting Interim Review	01/04/2008
More

Articles from the Sector

Medicsight	14/08/2008
Earnings rise at Southern Cross	11/08/2008
Assura welcomes NHS changes	06/08/2008
Southern wins loan extension	25/07/2008
Immunodiagnostic Systems	18/07/2008
Bid move at Meldex	17/07/2008
VivoMedica	16/07/2008
Synergy maintains growth	09/07/2008
Omega Diagnostics	08/07/2008
Southern Cross misses deadline	30/06/2008
More

Financial History

Financial Year End	31/12/2003	31/12/2004	31/12/2005	31/12/2006	31/12/2007
Currency	GBP	GBP	GBP	GBP	GBP
Turnover	10.85	12.22	12.12	15.46	22.91
Operating Profit	-0.34	0.40	1.23	2.16	2.23
Pretax Profit	0.42	1.31	2.25	3.18	2.82
Earnings After Tax	0.35	1.21	1.76	2.55	2.43
Profit Available For Dividend	0.00	0.00	0.00	0.00	0.00
Ordinary Dividends	0.00	0.00	0.00	0.00	0.00
Retained Profit	0.35	0.00	0.00	0.00	0.00
Shareholders Funds	30.83	32.17	34.01	36.56	39.10
Net Current Assets	22.65	0.00	0.00	0.00	0.00
Adjusted Earnings Per Share Undiluted	0.00	1.69	2.45	3.56	3.39
Adj Earnings Per Share	0.00	1.69	2.45	3.56	3.37
Dividend Per Share	0.00	0.00	0.00	0.00	0.50

Chart

Click here for interactive charting

Company Details
Address	Queensway, New Milton, BH25 5NN
Telephone	01425 624 600
Fax	01425 624 700
Executives
Chairman	James Hill (0.00% holding)
Chief Executive	Charles de Rohan (0.00% holding)
Finance Director	Andrew Kellett (0.04% holding)
Scientific Director	Julian Burke (1.80% holding)
Main Shareholders
	Liontrust Investments: 8.6% John Morgan: 7%
Advisers
Nominated Adviser	Piper Jaffray
Nominated Broker	Piper Jaffray
Solicitors	Olswang
Auditors	Deloitte
Registrar	Equiniti

Commentary
Cancer diagnostic and biotherapeutic technologies group
Company Data
Code	GTX
Sedol	GB00012768
Shares In Issue	71.779 m
Indices	TechmarkAllShare
Entry on AIM	02/06/2006
Interim Results	Aug
Final Results	Mar
Year End	Dec
Accounts Due	Apr
Int div payment	Sep
Fin div payment	Jun
Int net div per share	0.5
Fin net div per share	0.2
Probable CGT relief	Yes